<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tabansky I</submitter><funding>National Institutes of Health</funding><pagination>17</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6016871</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>BACKGROUND:Dendritic cells (DC) induce adaptive responses against foreign antigens, and play an essential role in maintaining peripheral tolerance to self-antigens. Therefore they are involved in preventing fatal autoimmunity. Selective delivery of antigens to immature DC via the endocytic DEC-205 receptor on their surface promotes antigen-specific T cell tolerance, both by recessive and dominant mechanisms. We provide evidence that the induction of antigen-specific T cell tolerance is not a unique property of CD11c+CD8+DEC-205+ DCs. METHODS:We employed a fusion between αDCIR2 antibodies and the highly encephalitogenic peptide 139-151 of myelin-derived proteolipid protein (PLP139-151), to target CD11c +CD8- DCs with a DEC-205-DCIR2+ phenotype in vivo, and to substantially improve clinical symptoms in the PLP139-151-induced model of experimental autoimmune encephalomyelitis (EAE). RESULTS:Consistent with previous studies targeting other cell surface receptors, EAE protection mediated by αDCIR2-PLP139-151 fusion antibody (Ab) depended on an immature state of targeted DCIR2+ DCs. The mechanism of αDCIR2-PLP139-151 mAb function included the deletion of IL-17- and IFN-γ-producing pathogenic T cells, as well as the enhancement of regulatory T (Treg) cell activity. In contrast to the effect of αDEC-205+ fusion antibodies, which involves extrathymic induction of a Foxp3+ Treg cell phenotype in naïve CD4+Foxp3- T cells, treatment of animals with DCIR2+ fusion antibodies resulted in antigen-specific activation and proliferative expansion of natural Foxp3+ Treg cells. CONCLUSIONS:These results suggest that multiple mechanisms can lead to the expansion of the Treg population, depending on the DC subset and receptor targeted.</pubmed_abstract><journal>Molecular medicine (Cambridge, Mass.)</journal><pubmed_title>Targeting DEC-205-DCIR2+ dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis.</pubmed_title><pmcid>PMC6016871</pmcid><funding_grant_id>NICHD F32 081835.</funding_grant_id><pubmed_authors>Funaro M</pubmed_authors><pubmed_authors>Wright P</pubmed_authors><pubmed_authors>Diamond B</pubmed_authors><pubmed_authors>Petzold C</pubmed_authors><pubmed_authors>Keskin DB</pubmed_authors><pubmed_authors>Najjar S</pubmed_authors><pubmed_authors>Mooney D</pubmed_authors><pubmed_authors>Sands W</pubmed_authors><pubmed_authors>Watts D</pubmed_authors><pubmed_authors>Kretschmer K</pubmed_authors><pubmed_authors>Cao Y</pubmed_authors><pubmed_authors>Stern JNH</pubmed_authors><pubmed_authors>Tabansky I</pubmed_authors><pubmed_authors>Yunis EJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting DEC-205-DCIR2+ dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis.</name><description>BACKGROUND:Dendritic cells (DC) induce adaptive responses against foreign antigens, and play an essential role in maintaining peripheral tolerance to self-antigens. Therefore they are involved in preventing fatal autoimmunity. Selective delivery of antigens to immature DC via the endocytic DEC-205 receptor on their surface promotes antigen-specific T cell tolerance, both by recessive and dominant mechanisms. We provide evidence that the induction of antigen-specific T cell tolerance is not a unique property of CD11c+CD8+DEC-205+ DCs. METHODS:We employed a fusion between αDCIR2 antibodies and the highly encephalitogenic peptide 139-151 of myelin-derived proteolipid protein (PLP139-151), to target CD11c +CD8- DCs with a DEC-205-DCIR2+ phenotype in vivo, and to substantially improve clinical symptoms in the PLP139-151-induced model of experimental autoimmune encephalomyelitis (EAE). RESULTS:Consistent with previous studies targeting other cell surface receptors, EAE protection mediated by αDCIR2-PLP139-151 fusion antibody (Ab) depended on an immature state of targeted DCIR2+ DCs. The mechanism of αDCIR2-PLP139-151 mAb function included the deletion of IL-17- and IFN-γ-producing pathogenic T cells, as well as the enhancement of regulatory T (Treg) cell activity. In contrast to the effect of αDEC-205+ fusion antibodies, which involves extrathymic induction of a Foxp3+ Treg cell phenotype in naïve CD4+Foxp3- T cells, treatment of animals with DCIR2+ fusion antibodies resulted in antigen-specific activation and proliferative expansion of natural Foxp3+ Treg cells. CONCLUSIONS:These results suggest that multiple mechanisms can lead to the expansion of the Treg population, depending on the DC subset and receptor targeted.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2025-04-04T19:33:57.526Z</modification><creation>2019-03-26T23:52:11Z</creation></dates><accession>S-EPMC6016871</accession><cross_references><pubmed>30134798</pubmed><doi>10.1186/s10020-018-0017-6</doi></cross_references></HashMap>